
{"result":[{"lastName":"Koong","clinicalFocus":[{"focus":"Pancreatic Cancer "},{"focus":"Pancreatic Cancer - Radiation Oncology"},{"focus":"Rectal Cancer - Radiation Oncology"},{"focus":"Liver Cancer - Radiation Oncology"},{"focus":"Stomach Cancer - Radiation Oncology"},{"focus":"Esophageal Cancer - Radiation Oncology"},{"focus":"Colorectal Cancer - Radiation Oncology"},{"focus":"Radiation Oncology"}],"appointments":[{"appointment":"Associate Professor,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4729&amp;type=small&amp;showNoImage","displayName":"Albert Koong","firstName":"Albert","href":"http://med.stanford.edu/profiles/Albert_Koong","researchInterest":"The focus of my laboratory is to understand the role of hypoxia and the tumor microenvironment on malignant progression. My clinical area of interest is in the application of chemoradiotherapy and stereotactic body radiotherapy (SBRT) for GI malignancies."},{"lastName":"Cho-Phan","clinicalFocus":[{"focus":"Gastrointestinal Cancers"},{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"}],"appointments":[{"appointment":"Clinical Assistant Professor,Medicine - Oncology"}],"primaryAppointment":"Clinical Assistant Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3864&amp;type=small&amp;showNoImage","displayName":"Cheryl Cho-Phan","firstName":"Cheryl","href":"http://med.stanford.edu/profiles/Cheryl_Cho-Phan","researchInterest":""},{"lastName":"Chang","clinicalFocus":[{"focus":"Radiation Oncology"},{"focus":"Cancer of the Stomach"},{"focus":"Cancer of Anus"},{"focus":"Cancer of Pancreas"},{"focus":"Cancer of the Rectum"},{"focus":"Cancer of the Liver"},{"focus":"Cancer of the Esophagus"},{"focus":"Cancer of the Head and Neck"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=8238&amp;type=small&amp;showNoImage","displayName":"Daniel Chang","firstName":"Daniel","href":"http://med.stanford.edu/profiles/Daniel_Chang","researchInterest":"I specialize in the treatment of gastrointestinal malignancies.  I am interested in developing stereotactic body radiotherapy for tumors of the liver, both primary and metastatic.  I am interested in developing functional imaging as a means of determining treatment response with radiation.  I am also interested in developing image-guided radiotherapy to improve radiation delivery for GI cancers to reduce toxicity and improve disease outcome."},{"lastName":"Norton","clinicalFocus":[{"focus":"Adrenal Cancer"},{"focus":"Carcinoid Tumors"},{"focus":"Carcinoid Tumors - Endocrinology"},{"focus":"Carcinoid Tumors - Surgery "},{"focus":"Endocrine - Surgery"},{"focus":"Endocrinology Surgery"},{"focus":"Esophageal Cancer"},{"focus":"Esophageal Cancer - Thoracic Surgery"},{"focus":"Gastrointestinal Cancers"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"Gastrointestinal Oncology Surgery"},{"focus":"General Surgery"},{"focus":"Liver Cancer"},{"focus":"Liver Cancer - Surgery"},{"focus":"Multiple Endocrine Neoplasias"},{"focus":"Multiple Endocrine Neoplasias - Surgery"},{"focus":"Osteosarcoma "},{"focus":"Osteosarcoma - Surgery"},{"focus":"Pancreas Surgery"},{"focus":"Pancreatic Cancer "},{"focus":"Pancreatic Cancer - Surgery"},{"focus":"Parathyroid Disease"},{"focus":"Parathyroid Disease - Surgery"},{"focus":"Sarcomas - Soft Tissue "},{"focus":"Sarcomas - Soft Tissue - Surgery"},{"focus":"Sarcomas - Surgical Oncology"},{"focus":"Stomach Cancer "},{"focus":"Stomach Cancer - Surgery"},{"focus":"Thyroid Cancers"},{"focus":"Thyroid Cancers - Surgery "}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3948&amp;type=small&amp;showNoImage","displayName":"Jeffrey Norton","firstName":"Jeffrey","href":"http://med.stanford.edu/profiles/Jeffrey_Norton","researchInterest":"Interleukin-12 is a Th1 cytokine.  It is important in the cell mediated immune response.  We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer.  We are planning a human trial."},{"lastName":"Swetter","clinicalFocus":[{"focus":"Pigmented Skin Lesions"},{"focus":"Melanoma"},{"focus":"Skin Cancer "},{"focus":"Basal/ Squamous Cell Carcinomas - VA Dermatology"},{"focus":"Dermatology"},{"focus":"Cutaneous Oncology"},{"focus":"Basal / Squamous Cell Carcinomas - Dermatology"},{"focus":"Pigmented Lesion and Melanoma Program"},{"focus":"Melanoma - Dermatology"},{"focus":"Pigmented Skin Lesions - Dermatology"},{"focus":"Pigmented Skin Lesions - Medical Oncology"},{"focus":"Skin Cancer - Dermatology"}],"appointments":[{"appointment":"Professor - Med Center Line,Dermatology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Dermatology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4215&amp;type=small&amp;showNoImage","displayName":"Susan Swetter, M.D.","firstName":"Susan","href":"http://med.stanford.edu/profiles/Susan_Swetter","researchInterest":"1) Early detection of melanoma through enhanced screening and professional and public education to improve melanoma awareness. 2) Chemoprevention of melanoma and nonmelanoma skin cancers in high-risk groups. 4) Epidemiologic and sociodemographic aspects of melanoma. 4) National dermatologist liaison to the ECOG Melanoma Committee and Co-founder/Co-Director of the Melanoma Prevention Working Group, an interdisciplinary Intergroup collaboration dedicated to melanoma control and prevention"},{"lastName":"Visser","clinicalFocus":[{"focus":"General Surgery"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Surgery - General Surgery"}],"primaryAppointment":"Assistant Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=8513&amp;type=small&amp;showNoImage","displayName":"Brendan C. Visser","firstName":"Brendan","href":"http://med.stanford.edu/profiles/Brendan_Visser","researchInterest":"My research interests span the breath of my clinical practice. Areas of active research include the multidisciplinary treatment of hepatocellular carcinoma, technical aspects of minimally invasive pancreatic and liver surgery, and pre-operative therapy for \"borderline\" resectable pancreatic cancer (to bring more patients to surgery).   I am also investigating trends in the management of hepatobiliary cancers in California, focusing on socioeconomic and instituional barriers to appropriate care."},{"lastName":"Poultsides","clinicalFocus":[{"focus":"Liver Neoplasms"},{"focus":"Pancreas Neoplasms"},{"focus":"Gastric Neoplasms"},{"focus":"Bile Duct Neoplasms"},{"focus":"Gallbladder Neoplasms"},{"focus":"Sarcoma"},{"focus":"Adrenal Neoplasms"},{"focus":"General Surgery"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Surgery - General Surgery"}],"primaryAppointment":"Assistant Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=14355&amp;type=small&amp;showNoImage","displayName":"George A. Poultsides, MD","firstName":"George","href":"http://med.stanford.edu/profiles/George_Poultsides","researchInterest":"Clinical trials of experimental therapeutics and outcomes analysis following combined modality treatment of hepatic, pancreatic, and gastrointestinal malignancies."},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4131&amp;type=small&amp;showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://med.stanford.edu/profiles/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Carlson","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty-Med Ctr Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Emeritus Faculty-Med Ctr Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4629&amp;type=small&amp;showNoImage","displayName":"Robert W. Carlson","firstName":"Robert","href":"http://med.stanford.edu/profiles/Robert_Carlson","researchInterest":"Clinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer."},{"lastName":"Colevas","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"developmental therapeutics"},{"focus":"investigational new drugs"},{"focus":"Adverse event( toxicity) evaluation and reporting"},{"focus":"Thyroid Cancer"},{"focus":"combined chemotherapy and radiation treatment"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Associate Professor - Med Center Line (By courtesy),Otolaryngology (Head and Neck Surgery)"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=8044&amp;type=small&amp;showNoImage","displayName":"Alexander Colevas","firstName":"Alexander","href":"http://med.stanford.edu/profiles/Alexander_Colevas","researchInterest":"Multi- modality treatment of Head and Neck Cancer\r\n\r\nPhase 1 clinical trials"},{"lastName":"Kunz","clinicalFocus":[{"focus":"Esophageal Cancer"},{"focus":"Gastrointestinal Cancers"},{"focus":"Neuroendocrine"},{"focus":"Oncology (Cancer)"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6035&amp;type=small&amp;showNoImage","displayName":"Pamela L. Kunz","firstName":"Pamela","href":"http://med.stanford.edu/profiles/Pamela_Kunz","researchInterest":"I specialize in the treatment of gastrointestinal malignancies.  My research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers."},{"lastName":"Shelton","clinicalFocus":[{"focus":"Rectal Cancer "},{"focus":"Colon and Rectal Surgery"},{"focus":"Colorectal Cancer"},{"focus":"Crohn's Disease"},{"focus":"Colorectal Cancer - Surgery"},{"focus":"Gastrointestinal Cancers"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"General Surgery"},{"focus":"Inflammatory Bowel Diseases"},{"focus":"Ulcerative Colitis"},{"focus":"Laparoscopic colorectal surgery"},{"focus":"Minimally Invasive Surgical Procedures"}],"appointments":[{"appointment":"Clinical Associate Professor,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Clinical Associate Professor,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3886&amp;type=small&amp;showNoImage","displayName":"Andrew A. Shelton, M.D.","firstName":"Andrew","href":"http://med.stanford.edu/profiles/Andrew_Shelton","researchInterest":"Multimodality treatment of rectal cancer\r\nSphincter preserving procedures for rectal cancer\r\nLaparoscopic colon and rectal surgery\r\nSurgical education"},{"lastName":"Ford","clinicalFocus":[{"focus":"Cancer Genetics"},{"focus":"Gastrointestinal Cancers - Genetics"},{"focus":"Gastrointestinal Cancers - Medical Oncology"},{"focus":"Breast Cancer - Genetics"},{"focus":"Ovarian Cancer - Genetics"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Associate Professor,Genetics"},{"appointment":"Associate Professor (By courtesy),Pediatrics"}],"primaryAppointment":"Associate Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4066&amp;type=small&amp;showNoImage","displayName":"James Ford","firstName":"James","href":"http://med.stanford.edu/profiles/James_Ford","researchInterest":"Mammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA\u000bdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer."},{"lastName":"Ganjoo","clinicalFocus":[{"focus":"Oncology"},{"focus":"Soft Tissue Sarcoma"},{"focus":"Gastrointestinal Stromal Tumors"},{"focus":"Ewing's Sarcoma"},{"focus":"Osteosarcoma"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6696&amp;type=small&amp;showNoImage","displayName":"Kristen N Ganjoo","firstName":"Kristen","href":"http://med.stanford.edu/profiles/Kristen_Ganjoo","researchInterest":"Non-Hodgkin's Lymphoma;\r\nSoft tissue sarcoma;\r\nOsteosarcoma."},{"lastName":"Dirbas","clinicalFocus":[{"focus":"General Surgery"},{"focus":"Accelerated Breast Radiation"},{"focus":"MRI in Breast Cancer Staging"},{"focus":"Minimally Invasive Breast Surgery"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4667&amp;type=small&amp;showNoImage","displayName":"Frederick M. Dirbas","firstName":"Frederick","href":"http://med.stanford.edu/profiles/Frederick_Dirbas","researchInterest":"My research interests are focused on minimizing the impact of breast cancer from a diagnostic and therapuetic standpoint. Breast MRI is a powerful tool to facilitate the screening for and staging of breast cancer, and can be valuable adjunct to guide breast surgery. Oncoplastic surgical techniques optimize cosmesis after breast cancer surgery. Accelerated radiotherapy after lumpectomy decreases radiotherapy treatment times from 6 weeks to just 1 to 5 days."},{"lastName":"Welton","clinicalFocus":[{"focus":"Anal Cancer "},{"focus":"Basal / Squamous Cell Carcinomas"},{"focus":"Basal / Squamous Cell Carcinomas - Surgery"},{"focus":"Carcinoid Tumors"},{"focus":"Carcinoid Tumors - Surgery "},{"focus":"Colon and Rectal Surgery"},{"focus":"Colorectal Cancer"},{"focus":"Colorectal Cancer - Surgery"},{"focus":"Gastrointestinal Cancers"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"Inflammatory Bowel Disease"},{"focus":"Rectal Cancer "},{"focus":"Rectal Cancer - Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3835&amp;type=small&amp;showNoImage","displayName":"Mark Lane Welton","firstName":"Mark","href":"http://med.stanford.edu/profiles/Mark_Welton","researchInterest":"Clinical research focused on the diagnosis, prevention and treatment of anal cancer and its precursor lesions.  Clinical trials of ablative therapy for High-grade Squamous Intraepithelial Lesions (HSIL) of the anus and perianal tissues as a means for preventing anal cancer.\r\nBasic science work in collaboration with Ronald Davis and Hanlee Ji focused on the molecular genetic and pathologic studies of anal cancers using moecular inversion probe genomic technology"},{"lastName":"Pegram","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=32170&amp;type=small&amp;showNoImage","displayName":"Mark Pegram","firstName":"Mark","href":"http://med.stanford.edu/profiles/Mark_Pegram","researchInterest":""},{"lastName":"Matsubara","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Stem Cell"}],"primaryAppointment":"Postdoctoral Research fellow, Stem Cell","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=24222&amp;type=small&amp;showNoImage","displayName":"Junichi Matsubara","firstName":"Junichi","href":"http://med.stanford.edu/profiles/Junichi_Matsubara","researchInterest":""},{"lastName":"Longacre","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6082&amp;type=small&amp;showNoImage","displayName":"Teri A Longacre","firstName":"Teri","href":"http://med.stanford.edu/profiles/Teri_Longacre","researchInterest":"Gynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4018&amp;type=small&amp;showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Chen","clinicalFocus":[{"focus":"Gastroenterology"},{"focus":"pancreatic cancer"},{"focus":"gastric cancer"},{"focus":"esophageal cancer"},{"focus":"Barrett's Esophagus"},{"focus":"colon cancer"},{"focus":"gastrointestinal cancer"},{"focus":"intestinal metaplasia"},{"focus":"endoscopic ultrasound"}],"appointments":[{"appointment":"Clinical Assistant Professor,Medicine - Gastroenterology & Hepatology"}],"primaryAppointment":"Clinical Assistant Professor,Medicine - Gastroenterology & Hepatology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10886&amp;type=small&amp;showNoImage","displayName":"Ann Chen","firstName":"Ann","href":"http://med.stanford.edu/profiles/Ann_Chen","researchInterest":"Dr. Chen's research focus includes various advanced therapeutic endoscopic procedures with focus on premalignant and malignant gastrointestinal diseases. Specifically, she is interested in early detection and treatment of pancreatic-biliary and gastrointestinal diseases utilizing interventional procedures such as endoscopic ultrasound, radiofrequency and cryoablation therapy, confocal microscopy, and small bowel enteroscopy."},{"lastName":"Goffinet","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4600&amp;type=small&amp;showNoImage","displayName":"Don Goffinet","firstName":"Don","href":"http://med.stanford.edu/profiles/Don_Goffinet","researchInterest":"Head and neck, interstitial\r\nBladder, prostate, breast\r\nIORT, stereotactic, pituitary (and brain)\r\nOsteos and other sarcomas, clinical hyperthermia"},{"lastName":"Srinivas","clinicalFocus":[{"focus":"Bladder Cancer"},{"focus":"Bladder Cancer - Medical Oncology"},{"focus":"Germ Cell Tumors"},{"focus":"Germ Cell Tumors - Medical Oncology"},{"focus":"Germ Cell Tumors - Urologic Oncology"},{"focus":"Kidney Cancer"},{"focus":"Kidney Cancer - Medical Oncology"},{"focus":"Male Cancers - Penile"},{"focus":"Male Cancers - Prostate "},{"focus":"Male Cancers - Testicular "},{"focus":"Oncology (Cancer)"},{"focus":"Penile Cancer"},{"focus":"Prostate Cancer"},{"focus":"Prostate Cancer - Medical Oncology"},{"focus":"Testicular Tumors"},{"focus":"Testicular Tumors - Medical Oncology"},{"focus":"Ureteral Cancer"},{"focus":"Ureteral Cancer - Medical Oncology"},{"focus":"Urethral Cancer"},{"focus":"Urethral Cancer - Medical Oncology"},{"focus":"Urologic Cancers"},{"focus":"Urologic Cancers - Medical Oncology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4350&amp;type=small&amp;showNoImage","displayName":"Sandy Srinivas","firstName":"Sandhya","href":"http://med.stanford.edu/profiles/Sandhya_Srinivas","researchInterest":"Clinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma"},{"lastName":"Quon","clinicalFocus":[{"focus":"Nuclear Medicine"},{"focus":"PET Scans"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Radiology - Nuclear Medicine"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Radiology - Nuclear Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6452&amp;type=small&amp;showNoImage","displayName":"Andrew Quon","firstName":"Andrew","href":"http://med.stanford.edu/profiles/Andrew_Quon","researchInterest":"Multimodality fusion imaging with PET, CT, and MRI for oncology.  \r\n\r\nTranslational research bringing new radiotracers to clinical use.\r\n\r\nCardiovascular multimodality PET/CT imaging."},{"lastName":"Liang","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Medicine"}],"primaryAppointment":"Postdoctoral Research fellow, Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=37890&amp;type=small&amp;showNoImage","displayName":"Ying Liang,MD,PHD","firstName":"Ying","href":"http://med.stanford.edu/profiles/Ying_Liang","researchInterest":"My clinical and research interest is to apply evolving technologies to the diagnosis, characterization, and individualized treatment of Thoracic cancer such as NSCLC, SCLC, Thymoma,Mesothelioma."}]}